IMUNON INC(NASDAQ:IMNN) stock News

IMNN Latest News, Press Relases and Analysis

All

Press Releases

18 days ago - By: Chartmill

IMUNON INC (NASDAQ:IMNN) Reports Mixed Q2 2025 Results with EPS Beat but Stock Decline

18 days ago - By: Imunon, Inc.

IMUNON Recaps Highlights from 2025 Second Quarter Financial Results Conference Call

18 days ago - By: Imunon, Inc.

IMUNON Reports Second Quarter 2025 Financial Results and Provides Business Update

18 days ago - By: Benzinga - Mentions: AFG CXDO YUM PACK ...

Earnings Scheduled For August 5, 2025

19 days ago - By: Benzinga

Insights into Imunon's Upcoming Earnings

25 days ago - By: Imunon, Inc.

IMUNON to Hold Second Quarter 2025 Financial Results and Business Update Conference Call on Tuesday, August 5, 2025

a month ago - By: Imunon, Inc.

IMUNON Announces Stock Dividend Boosting Shareholder Value

a month ago - By: Imunon, Inc.

IMUNON Announces Reverse Stock Split

a month ago - By: Imunon, Inc.

IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan

2 months ago - By: Imunon, Inc.

IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025

2 months ago - By: Imunon, Inc.

IMUNON Announces PlaCCine® DNA Vaccine Technology Abstract Selected for Oral Presentation at 10th International Conference on Vaccines Research & Development™

2 months ago - By: Virtual Investor Conferences - Mentions: NIKA TIVC ADIA STSS ...

Life Sciences Investor Forum: Now Available for Online Viewing

2 months ago - By: Virtual Investor Conferences - Mentions: NIKA TIVC ADIA STSS ...

Life Sciences Investor Forum Agenda Announced for June 11th-12th

3 months ago - By: Imunon, Inc.

IMUNON Announces Data Presented at ASCO Reinforces Unprecedented Overall Survival in Ovarian Cancer Phase 2 Study

3 months ago - By: Imunon, Inc.

IMUNON CEO RECAPS A YEAR OF CLINICAL ACHIEVEMENT AND SOLID FUNDAMENTALS

3 months ago - By: Yahoo Finance - Mentions: SIRI CVNA SCYX PEPG ...

Imunon, Inc. (IMNN) Raises $3.25M in Private Placement, Eyes $6.5M More

3 months ago - By: Imunon, Inc.

IMUNON INC (IMNN) Stock News

IMNN Latest News, Press Relases and Analysis

IMUNON INC (NASDAQ:IMNN) Reports Mixed Q2 2025 Results with EPS Beat but Stock Decline

IMUNON Recaps Highlights from 2025 Second Quarter Financial Results Conference Call

IMUNON Reports Second Quarter 2025 Financial Results and Provides Business Update

Earnings Scheduled For August 5, 2025

Insights into Imunon's Upcoming Earnings

IMUNON to Hold Second Quarter 2025 Financial Results and Business Update Conference Call on Tuesday, August 5, 2025

IMUNON Announces Stock Dividend Boosting Shareholder Value

IMUNON Announces Reverse Stock Split

IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan

IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025

IMUNON Announces PlaCCine® DNA Vaccine Technology Abstract Selected for Oral Presentation at 10th International Conference on Vaccines Research & Development™

Life Sciences Investor Forum: Now Available for Online Viewing

Life Sciences Investor Forum Agenda Announced for June 11th-12th

IMUNON Announces Data Presented at ASCO Reinforces Unprecedented Overall Survival in Ovarian Cancer Phase 2 Study

IMUNON CEO RECAPS A YEAR OF CLINICAL ACHIEVEMENT AND SOLID FUNDAMENTALS

Imunon, Inc. (IMNN) Raises $3.25M in Private Placement, Eyes $6.5M More

IMUNON Closes Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules